User profiles for A. Mathers
Alison E MatherQuadram Institute Bioscience Verified email at quadram.ac.uk Cited by 7656 |
Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. A previous guidance document …
guidance on the treatment of antimicrobial-resistant infections. A previous guidance document …
The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae
AJ Mathers, G Peirano, JDD Pitout - Clinical microbiology reviews, 2015 - Am Soc Microbiol
Escherichia coli sequence type 131 (ST131) and Klebsiella pneumoniae ST258 emerged in
the 2000s as important human pathogens, have spread extensively throughout the world, …
the 2000s as important human pathogens, have spread extensively throughout the world, …
Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Background The Infectious Diseases Society of America is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. This guidance document …
guidance on the treatment of antimicrobial-resistant infections. This guidance document …
[HTML][HTML] IL-13 is a driver of COVID-19 severity
…, JJ Loomba, SJ Ratcliffe, MD Poulter, AJ Mathers… - JCI insight, 2021 - ncbi.nlm.nih.gov
Immune dysregulation is characteristic of the more severe stages of SARS-CoV-2 infection.
Understanding the mechanisms by which the immune system contributes to COVID-19 …
Understanding the mechanisms by which the immune system contributes to COVID-19 …
Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …
Background Antimicrobial-resistant infections are commonly encountered in US hospitals
and result in significant morbidity and mortality. This guidance document provides …
and result in significant morbidity and mortality. This guidance document provides …
Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem …
Background The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date
guidance on the treatment of antimicrobial-resistant infections. The initial guidance …
guidance on the treatment of antimicrobial-resistant infections. The initial guidance …
[HTML][HTML] Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO …
…, G Rahav, AJ Mathers… - Infectious diseases and …, 2018 - Springer
Methods A total of 77 patients with confirmed/suspected CRE infection (bacteremia, hospital-acquired/ventilator-associated
bacterial pneumonia, complicated intra-abdominal infection, …
bacterial pneumonia, complicated intra-abdominal infection, …
Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC
…, TE Peto, DW Crook, AJ Mathers - Antimicrobial agents …, 2016 - Am Soc Microbiol
The recent widespread emergence of carbapenem resistance in Enterobacteriaceae is a
major public health concern, as carbapenems are a therapy of last resort against this family of …
major public health concern, as carbapenems are a therapy of last resort against this family of …
Clinical challenges treating Stenotrophomonas maltophilia infections: an update
…, R Humphries, JJ Lipuma, AJ Mathers… - JAC-antimicrobial …, 2022 - academic.oup.com
Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has emerged
as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes treating …
as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes treating …
[PDF][PDF] Infectious diseases society of america antimicrobial resistant treatment guidance: gram-negative bacterial infections
The rise in antimicrobial resistance (AMR) continues to be a global crisis [1, 2]. Collectively,
antimicrobial resistant pathogens caused more than 2.8 million infections and over 35,000 …
antimicrobial resistant pathogens caused more than 2.8 million infections and over 35,000 …